Friday - March 20, 2026

Category Archives: Pharmaceuticals & Biotech

Projecting the Global Neuromodulation Devices Market Size to Expand at a 9.44% CAGR Through 2032, DelveInsight Analysis

Neuromodulation Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neuromodulation devices market is experiencing rapid growth, … Continue reading →

Amyotrophic Lateral Sclerosis Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, GSK, Biogen, Ionis Pharmaceuticals

The Key Amyotrophic Lateral Sclerosis Companies in the market include – Amylyx Pharmaceuticals, Sanofi, Brainstorm Cell Therapeutics, AI Therapeutics, Ionis, Biogen, Helixmith, Sanofi, Denali Therapeutics, Transposon Therapeutics, Alector, GSK, NeuroSense Therapeutics, Biogen, Ionis Pharmaceuticals, Brainstorm Cell Therapeutics, Cytokinetics, Astellas Pharma, … Continue reading →

Projecting the Global Neurothrombectomy Devices Market Size to Expand at a 6.88% CAGR Through 2032, DelveInsight Analysis

Neurothrombectomy Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The neurothrombectomy devices market is largely driven by … Continue reading →

Atopic Dermatitis Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | GlaxoSmithKline PLC, Nestle SA, Pfizer Inc., Regeneron Pharma, Abbvie

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 120+ Atopic Dermatitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Complement 3 Glomerulopathy Market: Strong Pharma Growth Forecast Through 2034 – DelveInsight | NovelMed Therapeutics, Apellis Pharma, Novartis, Amyndas Pharma

The Key Complement 3 Glomerulopathy Companies in the market include – NovelMed Therapeutics, Apellis Pharmaceuticals, Novartis, Amyndas Pharmaceuticals, and others.   DelveInsight’s “Complement 3 Glomerulopathy Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Complement 3 … Continue reading →

Diabetic Foot Ulcers Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corp

The Key Diabetic Foot Ulcers Companies in the market include – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and others.   The Diabetic Foot Ulcers market is expected to … Continue reading →

Advanced Renal Cell Carcinoma Pipeline 2026: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Molecure S.A., Daiichi Sankyo, Janux Therapeutics, NiKang Therapeuti

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Advanced Renal Cell Carcinoma pipeline constitutes 50+ key companies continuously working towards developing 60+ Advanced Renal Cell Carcinoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Myelofibrosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Galecto Biotech, Lynk Pharma, Samus Therapeutics, Taiga Biotech, Bristol-Mye

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myelofibrosis pipeline constitutes 35+ key companies continuously working towards developing 40+ Myelofibrosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →

Pulmonary Fibrosis Clinical Trial Analysis 2026: 110+ Companies Advancing 140+ Therapies with Breakthrough Clinical Progress, analyses DelveInsight

Pulmonary Fibrosis Pipeline Pulmonary Fibrosis Companies include Boehringer Ingelheim, PureTech, Guangzhou JOYO Pharma, Tvardi Therapeutics, Pliant Therapeutics, GlaxoSmithKline, Amgen, Bristol-Myers Squibb, Endeavor Biomedicines, Syndax Pharmaceuticals, Regend Therapeutics, among others. According to DelveInsight’s latest evaluation, the global Pulmonary Fibrosis pipeline includes … Continue reading →

Obsessive Compulsive Disorder Market to Surpass USD 1 Billion by 2034 | 10+ Key Companies Driving Innovation, analyses DelveInsight

Obsessive Compulsive Disorder Market Obsessive Compulsive Disorder (OCD) companies include Biohaven Pharmaceuticals, AbbVie, AstraZeneca, MedtronicNeuro, Hoffmann-La Roche, Ortho-McNeil Pharmaceutical, Forest Laboratories, Eli Lilly and Company, Janssen-Ortho Inc., Pfizer, among others. DelveInsight’s report titled “Obsessive Compulsive Disorder Market Insights, Epidemiology, and … Continue reading →